InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2024-10-04 00:00:00 ET · period of report 2024-10-02 · accession 0001156039-24-000115 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2024-10-04 2024-10-02 ELV Kaye Mark EVP, CFO F - Tax $505.16 -2,818 20.2K -12% -$1.42M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-10-02 F D 2,818 $505.16 20,213 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.